Teckro, a global life sciences technology company, has named Dana Poff as COO, adding unparalleled expertise in clinical research services to its growing team.
With more than 28 years of combined health care and clinical research experience, Poff joins Teckro from ICON, a global clinical research organisation where she held senior global leadership roles in clinical operations, project management and alliance management. In her most recent role, she served as Chief of Staff reporting to the CEO.
“I am excited to be part of an organisation focused on simplifying the approach to conducting clinical trials and reducing the burden on sites and patients,” said Poff.
“I look forward to helping Teckro continue to build upon its significant clinical expertise that allows it to be a market leader in this space.”
Gary Hughes, Teckro Co-founder and CEO, said: “Dana’s knowledge and experience of managing global clinical trials is matched only by her energy and passion for making things better. She is a key addition to our leadership team and will have a big part to play in delivering solutions for our clients, global research sites and patients.”
Poff’s appointment comes on the back of the company raising $10 million in Series B financing, led by Sands Capital Ventures with participation from Bill Maris’ Section 32 venture fund, Founders Fund and private investors. The company has raised $17.8 million to date.
Teckro uses information retrieval and machine learning technologies to improve the speed and accuracy of clinical trial conduct. The Teckro digital platform is deployed at thousands of research sites in over 30 countries across multiple phases of clinical trials, including critical Phase III studies.
